Detalles de la búsqueda
1.
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
J Gastroenterol Hepatol
; 35(8): 1307-1316, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900959
2.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190299
3.
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 16(6): 619-29, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981818
4.
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer.
BMC Cancer
; 11: 349, 2011 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21834960
5.
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Blood
; 110(1): 54-8, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17387223
6.
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
J Clin Oncol
; 24(10): 1590-6, 2006 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16575010
Resultados
1 -
6
de 6
1
Próxima >
>>